{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/692d7130635c16d6404362d8/69cadf04e8519e977f04c0a7?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Market Brief – 30 Mar 2026","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/692d7130635c16d6404362d8/1774903001372-6519b651-a416-407e-af0c-69ef601d39aa.jpeg?height=200","description":"<p>In today’s episode of <em>Market Brief – After Hours</em>, markets open the week on a cautious footing as oil prices surge to multi-year highs, geopolitical tensions intensify, and technology stocks come under renewed pressure despite pockets of resilience in defensive sectors.</p><p>We break down the divergence across US equities, with the Dow Jones edging higher while the S&amp;P 500 moves closer to correction territory and the Nasdaq declines sharply as rising energy costs weigh heavily on growth stocks.</p><p>In Europe, markets rally across the STOXX 600, DAX, CAC 40, and FTSE 100, driven by defensive sector rotation, even as economic sentiment deteriorates sharply with weaker consumer confidence and mixed data across Germany, France, Italy, and the UK.</p><p>The episode also covers detailed Forex technical analysis across EUR/USD, GBP/USD, and USD/JPY as bearish momentum builds in European currencies while the dollar remains supported, alongside movements in Gold and Silver as both metals attempt to stabilise after recent volatility.</p><p>In equities, we highlight major movers including sharp declines in Boston Scientific, Viridian Therapeutics, Sysco, and Micron, alongside strong gains in United Therapeutics following positive clinical trial results.</p>","author_name":"Arshia Hadidi"}